Ledger.Open graph →
SEC Form D · filed March 9, 2022

Ceptur Therapeutics, Inc

Offering
$75.0M
Sold
$21.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HILLSBOROUGH, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Samuel I. Gunderson · HILLSBOROUGH, NJDirectorAaron I. Kantoff · HILLSBOROUGH, NJDirectorJim Sherrington · Spokane, WADirectorPaiman P. Ghoroghchian · Lexington, KYExec · DirectorDaniel I. Heller · HILLSBOROUGH, NJDirectorKenneth Kelly · Detroit, MIDirectorAaron I. Kantoff · HILLSBOROUGH, NJDirectorPaiman P. Ghoroghchian · Lexington, KYExec · DirectorDaniel I. Heller · HILLSBOROUGH, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗